Description
The Men’s Cancer Screen 2 tests for Prostate Specific Antigen Cancer Screen (PSA), CA-19-9 (Carbohydrate Antigen) cancer screen and the CEA (Carcinoembryonic Antigen). These 3 screening tests focus on the Prostate and Pancreas which are 2 of the major causes of cancer in aging men as well as a global screening test to detect cancer in the body.
The Prostate Specific Antigen (PSA) cancer screening test in blood is used to screen asymptomatic and symptomatic men for prostate cancer in order to help determine the necessity for a biopsy of the prostate and also in order to monitor the effectiveness of treatment for prostate cancer, or to detect recurrence of prostate cancer. The PSA blood test may be ordered during treatment of patients who have been diagnosed with prostate cancer to verify the effectiveness of treatment and at regular intervals after treatment to monitor for cancer recurrence.
CA 19-9 (Carbohydrate Antigen) cancer screen is often produced by pancreatic cancers, and its level is elevated in more than 90% of pancreatic cancers. It's typically used to gauge how well a treatment is working in those diagnosed with pancreatic cancer. CA 19-9 may be ordered along with other tests, such as carcinoembryonic antigen (CEA), bilirubin, and/or a liver panel, when a patient has symptoms that may indicate pancreatic cancer, including abdominal pain, nausea, weight loss, and jaundice. If CA 19-9 is initially elevated in pancreatic cancer, then it may be ordered during cancer treatment to monitor response and, on a regular basis following treatment, to help detect recurrence.
CEA (Carcinoembryonic Antigen) is ordered to determine whether cancer is present in the body and to monitor cancer treatment. When you have symptoms that suggest the possibility of cancer your doctor may prescribe this test. Also this test is performed before starting cancer treatment especially in patients with Gastro Intestinal cancer, as well as at intervals during and after therapy to monitor treatment and recovery. Physicians can use CEA results to determine the stage and extent of cancer, especially gastrointestinal (GI) and, in particular, colorectal cancer. CEA is also helpful in monitoring patients with cancer of the rectum, lung, breast, liver, pancreas, stomach, and ovary.